These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1147 related articles for article (PubMed ID: 19075127)
21. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma]. Li XM; DI B; Shang YD; Li J; Cheng JM Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035 [TBL] [Abstract][Full Text] [Related]
22. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis. Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681 [TBL] [Abstract][Full Text] [Related]
23. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma. Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523 [TBL] [Abstract][Full Text] [Related]
24. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma. Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099 [TBL] [Abstract][Full Text] [Related]
25. Management of contralateral N0 neck in oral cavity squamous cell carcinoma. Koo BS; Lim YC; Lee JS; Choi EC Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743 [TBL] [Abstract][Full Text] [Related]
26. Prospective validation of the Martinez-Gimeno clinicopathologic scoring system (MGSS) for evaluating risk of cervical lymph node metastases of squamous cell carcinoma of the oral cavity. Martínez-Gimeno C; Molinero AP; Castro V; Sastre MJ; Castro EE; Aguirre-Jaime A Head Neck; 2005 Apr; 27(4):320-5. PubMed ID: 15700293 [TBL] [Abstract][Full Text] [Related]
27. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706 [TBL] [Abstract][Full Text] [Related]
29. Intratumoral lymphatic vessels and VEGF-C expression are predictive factors of lymph node relapse in T1-T4 N0 laryngopharyngeal squamous cell carcinoma. Hinojar-Gutiérrez A; Fernández-Contreras ME; González-González R; Fernández-Luque MJ; Hinojar-Arzadún A; Quintanilla M; Gamallo C Ann Surg Oncol; 2007 Jan; 14(1):248-57. PubMed ID: 17066224 [TBL] [Abstract][Full Text] [Related]
30. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck. Do NY; Lim SC; Im TS Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682 [TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma of the floor of the mouth: tumour thickness and the rate of cervical metastasis. Wallwork BD; Anderson SR; Coman WB ANZ J Surg; 2007 Sep; 77(9):761-4. PubMed ID: 17685954 [TBL] [Abstract][Full Text] [Related]
32. [The effect of the microenvironment of head and neck cancers on tumor progression]. Lukits J Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327 [TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological study on patterns of cervical lymph node metastases from squamous cell carcinomas (SCC) of the head and neck]. Li X; Li L; Wei W Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):206-9. PubMed ID: 9642343 [TBL] [Abstract][Full Text] [Related]
34. [Expression of vascular endothelial growth factor C in laryngeal squamous carcinoma and its role in lymphatic metastasis]. Wang ZL; Chen Y; Zhou B; Liang CY; Zhang L; Li RX Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):47-9. PubMed ID: 14981813 [TBL] [Abstract][Full Text] [Related]
35. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study. Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374 [TBL] [Abstract][Full Text] [Related]
36. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. Kim SH; Cho NH; Kim K; Lee JS; Koo BS; Kim JH; Chang JH; Choi EC J Surg Oncol; 2006 Mar; 93(4):330-7. PubMed ID: 16496371 [TBL] [Abstract][Full Text] [Related]
37. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2. Meneses A; Verastegui E; Barrera JL; de la Garza J; Hadden JW Int Immunopharmacol; 2003 Aug; 3(8):1083-91. PubMed ID: 12860165 [TBL] [Abstract][Full Text] [Related]
38. [Significance and expression of vascular endothelial growth factor-C (VEGF-C) in esophageal squamous carcinoma and glioma]. Pang XH; Tian H; Liu ZY; Li SM; Liu ST; Tian GP Ai Zheng; 2003 Nov; 22(11):1166-9. PubMed ID: 14613645 [TBL] [Abstract][Full Text] [Related]
39. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma. Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142 [TBL] [Abstract][Full Text] [Related]
40. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings]. Esser D; Anke S; Roessner A; Freigang B Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]